HGG-34. Upfront Molecular Targeted Therapy for the Treatment of BRAF-mutant Pediatric High-Grade Glioma
Author(s) -
Tom Rosenberg,
Kee Kiat Yeo,
Audrey Mauguen,
Sanda Alexandrescu,
Sanjay P. Prabhu,
Jessica W. Tsai,
Seth Malinowski,
Mrinal Joshirao,
Karishma Parikh,
Sameer Farouk Sait,
Marc K. Rosenblum,
Jamal Benhamida,
George Michaiel,
Hung N. Tran,
Sonika Dahiya,
Kara Kachurak,
Gregory K. Friedman,
JulieI Krystal,
Michael Huang,
Ashley Margol,
Karen Wright,
Dolly Aguilera,
Tobey J. MacDonald,
Susan Chi,
Matthias A. Karajannis
Publication year - 2022
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/noac079.249
Subject(s) - medicine , atrx , glioma , oncology , anaplastic astrocytoma , cohort , targeted therapy , concomitant , cdkn2a , progression free survival , temozolomide , astrocytoma , cancer , cancer research , chemotherapy , mutation , gene , chemistry , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom